|
| |
Gilead SciencesGilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions forpatients and the people who care for them. The Company discovers, develops and commercializes proprietary therapeutics for important viral diseases, including the currently marketed product VISTIDE-Registered Trademark- (cidofovir injection) for the treatment of cytomegalovirus ("CMV") retinitis, a sight-threatening viral infection in patients with acquired immune deficiency syndrome ("AIDS"). In addition, the Company is developing products to treat diseases caused by human immunodeficiency virus ("HIV"), hepatitis B virus ("HBV") and influenza virus.
| Contact Details: |
| 333 Lakeside Drive |
| Foster City |
| CA |
| 94404 |
| United States of America |
| Tel: | 650 574 3000 |
| Fax: | 650 578 9264 |
| Email: | public_affairs@gilead.com |
| WWW: | www.gilead.com/
|
|
Loading...
|
Recent Publications by Gilead Sciences: |  |
Strand Transfer Inhibitors of HIV-1 Integrase: Bringing IN a New Era of Antiretroviral Therapy.
HIV-1 integrase (IN) is one of three essential enzymes (along with reverse... | 21st November, 2009
| Gilead Sciences, Inc, Foster City, 333 Lakeside Drive, 94404 CA.
| Antiviral Res. 2009 Nov 16.
DOI Direct Link |
Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor.
Mammalian serine racemase (SR) is a pyridoxal-5'-phosphate (PLP) dependent... | 18th November, 2009
| Gilead Sciences and IOCB Research Center, Institute of Organic Chemistry
| J Med Chem. 2009 Oct 8;52(19):6032-41.
DOI Direct Link |
RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.
Pyrimidinol carboxylic acids were designed as inhibitors of HIV-1 RNase H... | 18th November, 2009
| Department of Medicinal Chemistry, Gilead Sciences, Foster City,
| J Med Chem. 2009 Oct 8;52(19):5781-4.
DOI Direct Link |
Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
Two methods for preparation of 6-substituted derivatives of anti DNA-viral... | 17th November, 2009
| Institute of Organic Chemistry and Biochemistry, Academy of Sciences of
| Bioorg Med Chem. 2009 Oct 29.
DOI Direct Link |
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.
Twenty-five years ago, nucleoside analog 3'-azidothymidine (AZT) was shown... | 6th November, 2009
| Department of Biology, Gilead Sciences, Inc., 362 Lakeside Drive, Foster
| Antiviral Res. 2009 Nov 1.
DOI Direct Link |
→View more Gilead Sciences research publications. |
Press Releases on Gilead Sciences:
|
 |
| Pearl Therapeutics Appoints Howie Rosen to Board of Directors |
23rd November, 2009 |
Pearl Therapeutics Inc. |
REDWOOD CITY, Calif., Nov. 23 /PRNewswire/ -- Pearl Therapeutics Inc., a biopharmaceutical company developing therapeutic products for the treatment of chronic respiratory diseases, today announced
|
| Four Senior Executives Join Orexigen(R) Therapeutics Management Team |
23rd November, 2009 |
Orexigen Therapeutics, Inc. |
SAN DIEGO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that four senior executives have joined the organization, strengthening the management
|
| NeurogesX Expands Commercial Operations Leadership Team |
5th November, 2009 |
NeurogesX |
-- Timothy Arendt has been named Vice President Sales. He will implement
and manage the U.S. specialty sales force for Qutenza(TM).
-- Amy C. Cavers has joined NeurogesX as
|
| Asian American Stars to Unite for 'B HERE' Campaign October 27 and 28 |
22nd October, 2009 |
"B HERE" campaign |
-- Evening of Live Performances featuring some of the nation's most
entertaining young Asian American music, dance and comedy acts,
including emcee and YouTube sensation
|
| Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis |
16th October, 2009 |
Reportlinker |
NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry,
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 64 individuals from Gilead Sciences using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 536 times since April 2007, the link to the organisation's website has been followed 86 times Recent Search Terms used to find this page: European Patent Application Bivalent Binding Molecules of 7 Transmembrane G Protein-Coupled Receptors | Gilead Bioportfolio | Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin s Lymphoma | gilead sciences stock may 2009 | e-mail Gillead | Who does PR for Gilead Science | vistide in india | Gilead Science sales as of May 2009 | gilead sciences foster city | in vitro biology gilead | . Search for more companies in Foster City Search for more companies in CA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Gilead Sciences |
